Bioxyne Limited (ASX:BXN) Responds to ASX Price Query
Bioxyne Limited responds to ASX regarding recent trading activity, confirming compliance and lack of undisclosed information.
Bioxyne Limited responds to ASX regarding recent trading activity, confirming compliance and lack of undisclosed information.
Calidus Resources Limited announces upcoming Section 444GA hearings scheduled for December 2024 as part of its Deed of Company Arrangement.
Pro Medicus Limited secures a significant AUD $330M contract with Trinity Health to implement a cloud-based imaging platform.
PeopleIn Limited appoints Ross Thompson as Managing Director, adding experience and leadership to its Board.
The Hydration Pharmaceuticals Company Limited (ASX:HPC) reports significant progress in US operations, focusing on ecommerce growth and cost efficiencies.
Maggie Beer Holdings updates shareholders on FY24 results and growth strategies at the AGM, highlighting operational efficiency and strategic focus.
Maas Group (ASX:MGH) is set to raise up to $128 million for strategic acquisitions, enhancing its growth and market position.
Archer Materials Limited (ASX:AXE) has progressed its Biochip technology, improving accuracy for chronic kidney disease testing.
Southern Cross Gold Ltd (ASX:SXG) announced significant gold intercepts at its Sunday Creek project, expanding its known mineralisation zone.
Cann Group Limited (ASX: CAN) raises $2 million to support its growth initiatives through a successful entitlement offer.